Antioxidants, 2023 Genetics of Plasma Bilirubin and Associations between Bilirubin and Cardiometabolic Risk Profiles in Danish Children and Adolescents Ullah A., Stankevic E., Holm L. et al. Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma | | | | |
Journal of Cerebral Blood Flow & Metabolism, 2023 A cluster of blood-based protein biomarkers associated with decreased cerebral blood flow relates to future cardiovascular events in patients with cardiovascular disease Overmars L., Kuipers S., van Es B. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
iScience, 2023 Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19 Shivram H., Hackney J., Rosenberger C. et al. Olink Explore 3072/384Infectious DiseasesPathophysiologySerumBlood | | | | |
Nature Immunology, 2023 Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets Zhao J., Stacey D., Eriksson N. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
eClinicalMedicine, 2023 Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study Zinzani P., Trněný M., Ribrag V. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Nature Genetics, 2023 Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis Zhou S., Sosina O., Bovijn J. et al. Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma | | | | |
Research and Practice in Thrombosis and Haemostasis, 2023 Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach Liu Z., McCutcheon F., Ho H. et al. Olink Target 96CVDNeurologyPathophysiologyPlasma | | | | |
Environmental Science & Technology, 2023 Effects of Short- And Medium-Term Exposures to Lower Air Temperature on 71 Novel Biomarkers of Subclinical Inflammation: Results from the KORA F4 Study Ni W., Breitner S., Nikolaou N. et al. Olink Target 96Environmental Health & ToxicologyPathophysiologySerum | | | | |
Brain, Behavior, and Immunity, 2023 Machine learning models of plasma proteomic data predict mood in chronic stroke and tie it to aberrant peripheral immune responses Bidoki N., Zera K., Nassar H. et al. Olink Explore 3072/384NeurologyPatient StratificationPlasma | | | | |
Nature Aging, 2023 Multivariate genome-wide analysis of aging-related traits identifies novel loci and new drug targets for healthy aging Rosoff D., Mavromatis L., Bell A. et al. Olink Target 96AgingPathophysiologyPlasma | | | | |
International Journal of Obesity, 2023 Comprehensive analyses of circulating cardiometabolic proteins and objective measures of fat mass Titova O., Brunius C., Warensjö Lemming E. et al. Olink Target 96Metabolic DiseasesCVDEpidemiologyBlood | | | | |
Allergy, 2023 Dupilumab‐induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis Ryser F., Yalamanoglu A., Valaperti A. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |
Clinica Chimica Acta, 2023 Identification of novel candidate biomarkers for acute myocardial infarction by the Olink proteomics platform Liu J., Chen B., Lu H. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
European Journal of Internal Medicine, 2023 Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis Arias-de la Rosa I., Ruiz-Ponce M., Cuesta-López L. et al. Olink Target 96Immunological & Inflammatory DiseasesHepatologyPathophysiologyCell Culture Supernatant | | | | |
BMC Medicine, 2023 Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn’s disease Zhou L., Zhu L., Wu X. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |
Clinical Cancer Research, 2023 Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients Sarén T., Ramachandran M., Gammelgård G. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Frontiers in Cardiovascular Medicine, 2023 Baseline fibroblast growth factor 23 is associated with long-term mortality in ST-elevation myocardial infarction—results from the augsburg myocardial infarction registry Schmitz T., Wein B., Heier M. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Clinical Cancer Research, 2023 A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy Weiss S., Sznol M., Shaheen M. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Clinical Journal of the American Society of Nephrology, 2023 Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait Cai Y., Franceschini N., Surapaneni A. et al. Olink Explore 3072/384NephrologyHematologyPathophysiologyPlasma | | | | |
Cytokine, 2023 The role of NLRP3 in regulating gingival epithelial cell responses evoked by Aggregatibacter actinomycetemcomitans Jayaprakash Demirel K., Wu R., Neves Guimaraes A. et al. Olink Target 96Infectious DiseasesPathophysiologyCell Culture Supernatant | | | | |